TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive: The Med+TRAIL combination induced significant apoptosis in AML and BC-CML primary cells; but did not affect cell viability or induce significant cytotoxicity in primary normal human PBMCs, underscoring the translational relevance of the combination.